Adanyeguh, Isaac M.
Branzoli, Francesca
Delorme, Cécile
Méneret, Aurélie
Monin, Marie-Lorraine
Luton, Marie-Pierre
Durr, Alexandra
Sabidussi, Emanoel
Mochel, Fanny
Funding for this research was provided by:
programs “Investissements d’Avenir” (ANR-10-IAIHU-06, ANR-10-IAIHU-06)
Article History
Received: 11 November 2020
Accepted: 27 May 2021
First Online: 23 June 2021
Competing interests
: The following authors declare no competing interests: Adanyeguh, Luton, Monin, Delorme, Sabidussi. Dr Branzoli acknowledges support from the programs 'Institut des neurosciences translationnelle' ANR-10-IAIHU-06 and 'Infrastructure d’avenir en Biologie Santé' ANR-11-INBS-0006. Dr Méneret received travel grant from Abbvie. Prof Durr received research support from the French Agency for Research, Adverum, Pfizer Inc and Minoryx therapeutics. Dr Mochel received research support by grants from INSERM, the French Agency for Research, Carnot Institutes, ASL Foundation, Ultragenyx Pharmaceutical and Minoryx therapeutics.